인쇄하기
취소
|
It seems listed pharmaceutical companies’ effort to reduce sales management expenses has led to improvement in profitability.
According to the Yakup Shinmoon’s analysis result of the 3rd quarter’s performance reports of KOSPI and KOSDAQ pharmaceutical companies in 2015, the average ratio of sales management expenses to sales was 30.2% in the 3rd quarter.
The ratio was decreased by 0.8% from 3...